Brief: Glycomimetics Enters Into Acquisition Agreement With Crescent Biopharma
29/10/2024 11:20
Oct 29 (Reuters) - GlycoMimetics Inc GLYC.O :
* GLYCOMIMETICS ENTERS INTO ACQUISITION AGREEMENT WITH
CRESCENT
BIOPHARMA
* GLYCOMIMETICS INC - CONCURRENT FINANCING OF $200 MILLION
ANTICIPATED
* GLYCOMIMETICS INC - STOCKHOLDERS TO OWN APPROXIMATELY 3.1%
OF
COMBINED COMPANY
* GLYCOMIMETICS INC - CRESCENT STOCKHOLDERS TO OWN
APPROXIMATELY
96.9% OF COMBINED COMPANY
Source text: ID:nBw7wvfYVa
Further company coverage: GLYC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Crescent Biopharma
See all newsBrief: Crescent Biopharma - Potential To Initiate First CR-001 Phase 3 Study In Early 2028
Brief: Crescent Biopharma Announces FDA Clearance Of Ind Application For CR-002, A Pd-L1-Targeted Topoisomerase Inhibitor Adc, For The Treatment Of Solid Tumors
Crescent Biopharma posts smaller-than-expected Q2 net loss
U.S. STOCKS ON THE MOVE-Cintas, Veradermics
Crescent Biopharma slips on $125 mln share offering